Global Chronic Obstructive Pulmonary Disorder (COPD) Market Insights and Forecast to 2028

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Short-Acting Bronchodilators
1.2.3 Corticosteroids
1.2.4 Methylxanthines
1.2.5 Long-Acting Bronchodilators
1.2.6 Phosphodiesterase-4 Inhibitors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Perspective (2017-2028)
2.2 Chronic Obstructive Pulmonary Disorder (COPD) Growth Trends by Region
2.2.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Region (2017-2022)
2.2.3 Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Region (2023-2028)
2.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Dynamics
2.3.1 Chronic Obstructive Pulmonary Disorder (COPD) Industry Trends
2.3.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers
2.3.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Challenges
2.3.4 Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Revenue
3.1.1 Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Revenue (2017-2022)
3.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Players (2017-2022)
3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disorder (COPD) Revenue
3.4 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Ratio
3.4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2021
3.5 Chronic Obstructive Pulmonary Disorder (COPD) Key Players Head office and Area Served
3.6 Key Players Chronic Obstructive Pulmonary Disorder (COPD) Product Solution and Service
3.7 Date of Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Obstructive Pulmonary Disorder (COPD) Breakdown Data by Type
4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Type (2017-2022)
4.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Type (2023-2028)
5 Chronic Obstructive Pulmonary Disorder (COPD) Breakdown Data by Application
5.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Application (2017-2022)
5.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2017-2028)
6.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
6.2.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)
6.2.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028)
6.2.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2017-2028)
6.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
6.3.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)
6.3.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028)
6.3.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2017-2028)
6.4 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
6.4.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022)
6.4.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2017-2028)
7.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
7.2.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)
7.2.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028)
7.2.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2017-2028)
7.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
7.3.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)
7.3.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028)
7.3.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2017-2028)
7.4 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
7.4.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022)
7.4.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2017-2028)
8.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2017-2028)
8.4 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region
8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2017-2028)
9.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
9.2.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)
9.2.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028)
9.2.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2017-2028)
9.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
9.3.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)
9.3.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028)
9.3.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2017-2028)
9.4 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
9.4.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022)
9.4.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2017-2028)
10.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type
10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application
10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2017-2028)
10.4 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country
10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.7.5 Teva Pharmaceuticals Recent Developments
11.8 Ario Pharma
11.8.1 Ario Pharma Company Details
11.8.2 Ario Pharma Business Overview
11.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.8.5 Ario Pharma Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.9.5 Roche Recent Developments
11.10 Ache
11.10.1 Ache Company Details
11.10.2 Ache Business Overview
11.10.3 Ache Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.10.5 Ache Recent Developments
11.11 Almirall
11.11.1 Almirall Company Details
11.11.2 Almirall Business Overview
11.11.3 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.11.4 Almirall Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.11.5 Almirall Recent Developments
11.12 Aquinox Pharmaceuticals
11.12.1 Aquinox Pharmaceuticals Company Details
11.12.2 Aquinox Pharmaceuticals Business Overview
11.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.12.4 Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.12.5 Aquinox Pharmaceuticals Recent Developments
11.13 Asmacure
11.13.1 Asmacure Company Details
11.13.2 Asmacure Business Overview
11.13.3 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.13.4 Asmacure Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.13.5 Asmacure Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Introduction
11.14.4 Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022)
11.14.5 Astellas Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Short-Acting Bronchodilators
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Methylxanthines
Table 5. Key Players of Long-Acting Bronchodilators
Table 6. Key Players of Phosphodiesterase-4 Inhibitors
Table 7. Key Players of Others
Table 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Region (2017-2022)
Table 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Region (2023-2028)
Table 14. Chronic Obstructive Pulmonary Disorder (COPD) Market Trends
Table 15. Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers
Table 16. Chronic Obstructive Pulmonary Disorder (COPD) Market Challenges
Table 17. Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints
Table 18. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Share by Players (2017-2022)
Table 20. Global Top Chronic Obstructive Pulmonary Disorder (COPD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder (COPD) as of 2021)
Table 21. Ranking of Global Top Chronic Obstructive Pulmonary Disorder (COPD) Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chronic Obstructive Pulmonary Disorder (COPD) Product Solution and Service
Table 25. Date of Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2017-2022)
Table 29. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2023-2028)
Table 31. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Share by Application (2017-2022)
Table 33. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Share by Application (2023-2028)
Table 35. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2023-2028) & (US$ Million)
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 68. GSK Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 69. GSK Recent Developments
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 73. Pfizer Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 74. Pfizer Recent Developments
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 78. Merck Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 79. Merck Recent Developments
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 83. Novartis Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 84. Novartis Recent Developments
Table 85. AstraZeneca Company Details
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 88. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 89. AstraZeneca Recent Developments
Table 90. Boehringer Ingelheim Company Details
Table 91. Boehringer Ingelheim Business Overview
Table 92. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 93. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 94. Boehringer Ingelheim Recent Developments
Table 95. Teva Pharmaceuticals Company Details
Table 96. Teva Pharmaceuticals Business Overview
Table 97. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 98. Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 99. Teva Pharmaceuticals Recent Developments
Table 100. Ario Pharma Company Details
Table 101. Ario Pharma Business Overview
Table 102. Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 103. Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 104. Ario Pharma Recent Developments
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 108. Roche Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 109. Roche Recent Developments
Table 110. Ache Company Details
Table 111. Ache Business Overview
Table 112. Ache Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 113. Ache Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 114. Ache Recent Developments
Table 115. Almirall Company Details
Table 116. Almirall Business Overview
Table 117. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 118. Almirall Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 119. Almirall Recent Developments
Table 120. Aquinox Pharmaceuticals Company Details
Table 121. Aquinox Pharmaceuticals Business Overview
Table 122. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 123. Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 124. Aquinox Pharmaceuticals Recent Developments
Table 125. Asmacure Company Details
Table 126. Asmacure Business Overview
Table 127. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 128. Asmacure Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 129. Asmacure Recent Developments
Table 130. Astellas Pharma Company Details
Table 131. Astellas Pharma Business Overview
Table 132. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product
Table 133. Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2017-2022) & (US$ Million)
Table 134. Astellas Pharma Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type: 2021 VS 2028
Figure 2. Short-Acting Bronchodilators Features
Figure 3. Corticosteroids Features
Figure 4. Methylxanthines Features
Figure 5. Long-Acting Bronchodilators Features
Figure 6. Phosphodiesterase-4 Inhibitors Features
Figure 7. Others Features
Figure 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application: 2021 VS 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Chronic Obstructive Pulmonary Disorder (COPD) Report Years Considered
Figure 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Region: 2021 VS 2028
Figure 15. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Players in 2021
Figure 16. Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder (COPD) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2021
Figure 18. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2028)
Figure 20. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2028)
Figure 21. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size Share by Country (2017-2028)
Figure 22. United States Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2028)
Figure 26. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2028)
Figure 27. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Share by Country (2017-2028)
Figure 28. Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size Share by Region (2017-2028)
Figure 38. China Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size Share by Country (2017-2028)
Figure 48. Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Chronic Obstru

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs